Pilot Study Evaluates Telemedicine-Delivered MI-CBT for Substance Use Disorders — Implications for Australian Practice

References

1. 1.Craig
2. 2.P.
3. 3.Dieppe
4. 4.P.
5. 5.Macintyre
6. 6.S.
7. 7.Michie
8. 8.S.
9. 9.Nazareth
10. 10.I.
11. 11.& Petticrew
12. 12.M. (2008). Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ
13. 13.337
14. 14.a1655. https://doi.org/10.1136/bmj.a1655
15. 15.Degenhardt
16. 16.L.
17. 17.Glantz
18. 18.M.
19. 19.Evans‐Lacko
20. 20.S.
21. 21.Sadikova
22. 22.E.
23. 23.Sampson
24. 24.N.
25. 25.Thornicroft
26. 26.G.
27. 27.... & Kessler
28. 28.R. C. (2017). Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys. World Psychiatry
29. 29.16(3)
30. 30.299-307. https://doi.org/10.1002/wps.20457
31. 31.Jesse
32. 32.S.
33. 33.Bråthen
34. 34.G.
35. 35.Ferrara
36. 36.M.
37. 37.Keindl
38. 38.M.
39. 39.Ben‐Menachem
40. 40.E.
41. 41.Tanasescu
42. 42.R.
43. 43.... & Ludolph
44. 44.A. C. (2017). Alcohol withdrawal syndrome: mechanisms
45. 45.manifestations
46. 46.and management. Acta Neurologica Scandinavica
47. 47.135(1)
48. 48.4-16. https://doi.org/10.1111/ane.12671
49. 49.Lin
50. 50.L. A.
51. 51.Fernandez
52. 52.A. C.
53. 53.& Bonar
54. 54.E. E. (2020). Telehealth for substance-using populations in the age of coronavirus disease 2019: Recommendations to enhance adoption. JAMA Psychiatry
55. 55.77(12)
56. 56.1209-1210. https://doi.org/10.1001/jamapsychiatry.2020.1698
57. 57.Miller
58. 58.W. R.
59. 59.& Rollnick
60. 60.S. (2012). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.
61. 61.University of Michigan. (2024). Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD). ClinicalTrials.gov. NCT04768920. https://clinicaltrials.gov/study/NCT04768920
62. 62.Uscher‐Pines
63. 63.L.
64. 64.Sousa
65. 65.J.
66. 66.Raja
67. 67.P.
68. 68.Mehrotra
69. 69.A.
70. 70.Barnett
71. 71.M. L.
72. 72.& Huskamp
73. 73.H. A. (2020). Suddenly becoming a "virtual doctor": experiences of psychiatrists transitioning to telemedicine during the COVID‐19 pandemic. Psychiatric Services
74. 74.71(11)
75. 75.1143-1150. https://doi.org/10.1176/appi.ps.202000250